Green Cross Cell Corp. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
7,675
2,251
2,994
93
718
Depreciation, Depletion & Amortization
1,054
839
839
843
1,063
Other Funds
5
1
-
-
-
Funds from Operations
5,146
2,001
3,363
2,025
4,854
Changes in Working Capital
6,620
4,342
868
855
3,665
Net Operating Cash Flow
1,475
2,341
4,231
2,881
8,519
Capital Expenditures
423
1,326
5,028
13,593
30,252
Sale of Fixed Assets & Businesses
19
6
25
7
29
Purchase/Sale of Investments
2,517
1,875
4,988
8,243
48,239
Net Investing Cash Flow
2,771
587
5
5,948
78,462
Cash Dividends Paid - Total
-
-
-
-
584
Issuance/Reduction of Debt, Net
560
2,132
2,389
315
69,409
Net Financing Cash Flow
61
2,183
2,389
315
68,816
Net Change in Cash
4,307
663
1,992
3,366
1,127
Free Cash Flow
1,811
3,527
665
8,080
13,788
Deferred Taxes & Investment Tax Credit
37
174
130
138
-
Other Sources
279
100
90
60
-
Change in Capital Stock
504
51
-
-
9
Exchange Rate Effect
-
234
144
16
-
Other Uses
129
67
70
665
-

About Green Cross Cell

View Profile
Address
6/F, SJ Technoville
Seoul SL 08511
Korea, Republic Of
Employees -
Website http://www.greencrosscell.com
Updated 09/14/2018
Green Cross Cell Corp. engages in the provision of anti-cancer immunotherapy. It operates through following businesses: Cancer Immunotherapy, Cord Blood Cryopreservation and KGMP Service. The company was founded on September 17, 1992 and is headquartered in Seoul, South Korea.